Complix N.V.
BioTech/Drugs - N/A, N/A, BE
Complix N.V. Details
A biotech company dedicated to the discovery and development of protein therapeutics using its proprietary alphabody™ technology. Alphabodies are robust and versatile protein scaffolds, unrelated to immunoglobulins, and inspired by naturally occurring motives. Complix's proprietary Cell Penetrating Alphabody (CPAB) technology allows it to access a broad range of intracellular disease related targets that are considered "intractable" by currently available drug formats, such as antibodies and small molecules.
Website:
complix.com
Employees:
20 - 49
HQ:
N/A
Location:
N/A, N/A, BE
Revenue:
2.5 - 5 Million
Complix N.V. Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Shutterstock
Online Video Platforms
Vimeo